For decades , doctors have sought viable treatments for treatment-resistant mood disorders. Emerging research points to this novel drug therapy, provided typically intravenously , appears to offer considerable breakthrough for patients who haven’t responded from conventional antidepressants . While largely considered a developing treatment , init